J. Craig Venter and the trouble with a finished map

The cell was working. That was the awkward part. In 2016, J. Craig Venter and his collaborators reported a bacterium with a genome pared down to 473 genes. It could reproduce under laboratory conditions. Yet the biological functions of 149 of those genes remained unknown. They had reduced the instructions, tested the result and still found a substantial portion of the machinery without an explanation.

For a researcher associated with reading the human genome, this was a useful rebuke to the idea that a sequence is the same thing as understanding. You could know the letters and still have questions about the sentence. Venter’s career kept producing versions of that predicament: a map that worked, an achievement worth announcing, and something beyond its edge that demanded another experiment.

He died in San Diego on April 29, 2026, aged 79. The route to those 473 genes had passed through a Southern California surf scene, a university laboratory, a White House ceremony and a yacht collecting seawater. It was an unusual itinerary for someone working on such small things.

The surfer gets a laboratory

John Craig Venter was born in Salt Lake City on October 14, 1946. School did little to advertise the career ahead. He later described himself as a late bloomer and his high-school performance as dismal. After high school, he moved from the Bay Area to Southern California to surf. The attraction was the water; university would come later.

Following service as a Navy corpsman in Vietnam in 1967 and 1968, he pursued his education at UC San Diego. He earned his undergraduate degree in biochemistry in 1972 and his doctorate in physiology and pharmacology in 1975. Those dates give the career a tidy appearance. The earlier detour is what makes them interesting. His attention had found somewhere to go.

At UC San Diego, the biochemist Nathan Kaplan mentored him, and the young undergraduate was given access to a research laboratory. Years later, Venter remembered a small campus, still being built, where encounters with scientists changed his direction. Kaplan’s influence lasted beyond any particular experiment. He encouraged acting on ideas and accepting the possibility that they might fail.

“It is the execution of ideas that makes the difference in science.”

J. Craig Venter, recalling Nathan Kaplan’s influence

It is easy to admire that sentiment after an experiment succeeds. Its practical demands arrive earlier, when the work still might go nowhere. Venter repeatedly chose projects at that less comfortable stage. The former surfer had found an occupation with plenty of opportunities to get knocked off the board.

Break it into pieces

He began his academic career in Buffalo, then moved to the National Institutes of Health in 1984. In 1991, he and colleagues published work on expressed sequence tags, or ESTs. These short sequences offered a way to identify genes rapidly by sampling DNA copies of expressed RNA. The approach made discovery more scalable without requiring every gene to be read completely first.

Venter founded The Institute for Genomic Research, known as TIGR, in 1992. Three years later, its researchers and collaborators published the complete genome of Haemophilus influenzae Rd: 1,830,137 DNA base pairs. It was the first complete genome sequence of a free-living organism. Hamilton Smith was among the collaborators whose work made the result possible.

The method had an almost impolite simplicity. Break the genome into pieces, sequence those pieces, then use their overlaps to reconstruct the whole with a computer. The name, whole-genome shotgun sequencing, did not suggest a delicate procedure. The computational task certainly was one. Success depended on being able to turn many disconnected readings into a reliable assembly.

In his later recollections, Venter described a funding system that was more comfortable supporting established work than attempting an uncertain experiment. The bacterial genome became evidence for his argument. Once a method had worked, its prospects looked different. His appetite for independent funding and new organizations makes sense in that setting: an institution could be another instrument for getting an experiment done.

A race, a podium, a joke

In 1998, he founded Celera Genomics to sequence the human genome. The public Human Genome Project was already under way. Now there was a private effort with a different assembly strategy, expensive sequencing equipment and an ambition that invited comparison. Biology had acquired a competition that could be followed well beyond the laboratory.

The story arrived at the White House on June 26, 2000. Venter and Francis Collins, a leader of the public effort, stood with President Bill Clinton as working drafts were announced. Before discussing the genetic code, Venter offered a measurement requiring no laboratory equipment: “I’m shorter than the previous two speakers.” The room laughed.

That small joke usefully punctures the solemnity of the familiar photograph. There were people at the podium, and many more behind them. The public consortium and Celera had each assembled a draft. Their analyses appeared in separate scientific publications in 2001. A working draft still contained gaps; subsequent work continued improving the sequence.

Celera’s paper described a consensus sequence drawn from five individuals. In 2007, a team led by Sam Levy published Venter’s own diploid genome, representing the two chromosome sets inherited from his parents. The person whose name accompanied so many sequencing announcements had become the subject of one. That same year, he published his autobiography, A Life Decoded. His life and its biological record now occupied rather different kinds of pages.

The yacht becomes an instrument

The water had never disappeared from the story. Venter had a sailing vessel, Sorcerer II, and the sequencing methods suggested a purpose for it beyond travel. A pilot project in the Sargasso Sea in 2003 examined microbial DNA in seawater. The results encouraged a larger question: how would those communities differ across the world’s oceans?

The Global Ocean Sampling Expedition launched in 2004. During a circumnavigation completed in 2006, Sorcerer II traveled 32,000 nautical miles and visited 23 countries and island groups on four continents. The inspiration included earlier voyages of scientific discovery. Venter’s collecting apparatus was designed for creatures a passing sailor would never notice.

Sampling meant drawing water aboard, passing it through progressively finer filters and preserving what those filters caught. DNA could then be extracted and sequenced back in the laboratory. A collection of fragments gave researchers access to a community, including organisms that were difficult to grow in culture. The voyage linked the pleasures of going somewhere with the demands of bringing back usable material.

The physical arrangements had their own charm. A contemporary account described surfboards lashed to the deck alongside the vessel’s scientific equipment. The boat did not require its owner to abandon his earlier interests. It had given those interests an increasingly elaborate job description.

Results published in 2007 included millions of new genes and previously unrecognized protein families. Data were deposited for other researchers to use. The ocean became a site for comparing organisms, environments and biological possibilities. Later expeditions extended the sampling, and Venter and the writer David Ewing Duncan eventually recounted the voyages in The Voyage of Sorcerer II, published in 2023.

There is a pleasing reversal here. Human genome sequencing had put our species at the center of the announcement. Ocean sampling directed attention toward life that needed filters and computers to become legible. The famous researcher was collecting evidence of how much had escaped everyone’s notice.

The instructions have to work

Meanwhile, another line of work was testing whether a genome could be built chemically and used to control a cell. In 2010, researchers led by Daniel Gibson, with Venter, Smith, Clyde Hutchison and other colleagues, reported a bacterial cell controlled by a synthesized genome. The chromosome contained about 1.08 million base pairs.

An existing recipient cell supplied the cellular machinery. The accomplishment was the synthetic genome and its successful operation inside that cell. Precision matters here, because the shorthand can make the experiment sound as if every component had been created from chemicals on an empty bench. The actual result was specific enough to be interesting without that embellishment.

During the work, one missing DNA base in an essential gene prevented successful transplantation. Finding and correcting it helped the experiment proceed. An announcement can make a result look inevitable. A single-letter error restores a sense of the stubborn work beneath it. Biology is a demanding proofreader, and it does not offer encouraging partial credit.

The 2016 minimal-genome project then reduced the gene set through cycles of design, construction and testing. Some genes that seemed dispensable proved necessary for robust growth. The eventual 473-gene cell functioned in its laboratory setting, while those 149 unexplained gene functions kept the task of understanding it open.

The pleasure of an unfinished map

Venter also built companies, including Synthetic Genomics and Human Longevity, Inc., which he co-founded with Peter Diamandis and Robert Hariri. Organizations and books gave him other ways to pursue and explain his ideas. Life at the Speed of Light, published in 2013, explored the relationship between genetic information and synthetic biology.

He continued giving collaborators their place in the account. In November 2025, he wrote about Hamilton Smith and the partnership that had connected bacterial sequencing, the human genome and synthetic genomes. The recurring names matter. A biography can follow one person without assigning that person every experiment.

Asked about retirement in 2023, Venter said he considered it tantamount to death. The sentiment fits a career whose apparent endings repeatedly opened onto further work. He could help assemble a genome, then head out looking for more of them. He could help make a cell function, then confront how much of its operation remained unexplained.

Return to those 149 genes. They leave a better closing image than a trophy cabinet: a functioning cell, a carefully counted result and a set of unanswered questions. Venter had spent decades improving the tools for looking. The view kept getting larger.